Specijalna Bolnica, Radiochirurgia Zagreb, Franje Tuđmana 4, 10431 Sveta Nedelja, Croatia.
Sveučilište Josipa Jurja Strossmayera u Osijeku, Medicinski Fakultet Osijek, Josipa Huttlera 4, 31000 Osijek, Croatia.
Curr Oncol. 2021 Nov 11;28(6):4597-4610. doi: 10.3390/curroncol28060389.
(1) Background: the aims of this study were to determine the total extent of pancreatic cancer's internal motions, using Calypso extracranial tracking, and to indicate possible clinical advantages of continuous intrafractional fiducial-based tumor motion tracking during SABR. (2) Methods: thirty-four patients were treated with SABR for LAPC using Calypso for motion management. Planning MSCTs in FB and DBH, and 4D-CTs were performed. Using data from Calypso and 4D-CTs, the movements of the lesions in the CC, AP and LR directions, as well as the volumes of the 4D-CT-based ITV and the volumes of the Calypso-based ITV were compared. (3) Results: significantly larger medians of tumor excursions were found with Calypso than with 4D-CT: CC: 29 mm ( < 0.001); AP: 14 mm ( < 0.001) and LR: 11 mm ( < 0.039). The median volume of the Calypso-based ITV was significantly larger than that of the 4D-CT based ITV ( < 0.001). (4) Conclusion: beside known respiratory-induced internal motions, pancreatic cancer seems to have significant additional motions which should be considered during respiratory motion management. Only direct and continuous intrafractional fiducial-based motion tracking seems to provide complete coverage of the target lesion with the prescribed isodose, which could allow for safe tumor dose escalation.
(1) 背景:本研究旨在使用 Calypso 颅外追踪技术确定胰腺癌的整体内部运动范围,并表明在 SABR 期间连续基于内靶点的肿瘤运动跟踪可能具有临床优势。(2) 方法:34 例接受 SABR 治疗的 LAPC 患者采用 Calypso 进行运动管理。进行了 FB 和 DBH 计划 MSCT 和 4D-CT。利用 Calypso 和 4D-CT 数据,比较了病变在 CC、AP 和 LR 方向上的运动以及基于 4D-CT 的 ITV 体积和基于 Calypso 的 ITV 体积。(3) 结果:与 4D-CT 相比,Calypso 发现肿瘤位移的中位数明显更大:CC:29mm(<0.001);AP:14mm(<0.001)和 LR:11mm(<0.039)。基于 Calypso 的 ITV 的中位数体积明显大于基于 4D-CT 的 ITV(<0.001)。(4) 结论:除了已知的呼吸诱导的内部运动外,胰腺癌似乎还有明显的额外运动,在呼吸运动管理中应考虑这些运动。只有直接和连续的基于内靶点的运动跟踪似乎才能提供完整的靶区覆盖,并保证规定的等剂量,这可能允许安全地提高肿瘤剂量。